Status:
NOT_YET_RECRUITING
Tranexamic Acid for Anaemia Trial
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
The Jon Moulton Charity Trust
Conditions:
Anemia
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Anaemia is a common health problem in women. It is often due to iron deficiency. Anaemia is a particular problem during pregnancy and is bad for the mother and baby. It is best to treat anaemia in you...
Detailed Description
World-wide, half a billion women of reproductive age are anaemic. Anaemia has major health consequences for pregnant women and their babies. Anaemia increases the risk of ante-partum haemorrhage, prem...
Eligibility Criteria
Inclusion
- Adult women (aged 18 years and older)
- Having menstrual periods every 21 to 38 days that last 2 to 9 days
- Having anaemia (Hb \< 120 g/L) according to point-of-care finger prick screening test
- Willing to provide informed consent and able to attend study visits during the trial period
- (Individuals with known thalassaemia are eligible to participate and take the trial treatment but will not receive standard of care iron supplementation. They will continue to receive their standard care.)
Exclusion
- Planning to get pregnant during trial period
- Already taking TXA
- Known to have contraindications to TXA treatment (including allergy to TXA or its excipients, renal impairment, active thromboembolic disease, history of venous or arterial thrombosis, history of convulsion.)
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT06519422
Start Date
September 1 2025
End Date
September 1 2028
Last Update
July 25 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.